RGT 12.1% 25.5¢ argent biopharma limited

Epidiolex development is initially concentrating on severe,...

  1. 2,106 Posts.
    lightbulb Created with Sketch. 461
    Epidiolex development is initially concentrating on severe, orphan, early-onset, treatment-resistant epilepsy syndromes including Dravet syndrome, Lennox-Gastaut syndrome (LGS) and Tuberous Sclerosis Complex (TSC).
 
watchlist Created with Sketch. Add RGT (ASX) to my watchlist
(20min delay)
Last
25.5¢
Change
-0.035(12.1%)
Mkt cap ! $13.83M
Open High Low Value Volume
25.5¢ 25.5¢ 25.5¢ $465 1.824K

Buyers (Bids)

No. Vol. Price($)
2 4408 25.0¢
 

Sellers (Offers)

Price($) Vol. No.
29.0¢ 8264 3
View Market Depth
Last trade - 12.38pm 11/11/2024 (20 minute delay) ?
RGT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.